Gene Therapy of Cancer

Translational Approaches from Preclinical Studies to Clinical Implementation

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Science & Nature, Science, Biological Sciences, Genetics
Cover of the book Gene Therapy of Cancer by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780123946324
Publisher: Elsevier Science Publication: August 28, 2013
Imprint: Academic Press Language: English
Author:
ISBN: 9780123946324
Publisher: Elsevier Science
Publication: August 28, 2013
Imprint: Academic Press
Language: English

Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical and clinical studies have led to the design and testing of new therapeutic approaches. The Third Edition of Gene Therapy of Cancer provides crucial updates on the basic and applied sciences of gene therapy. It offers a comprehensive assessment of the field including the areas of suicide gene therapy, oncogene and suppressor gene targeting, immunotherapy, drug resistance gene therapy, and the genetic modification of stem cells. Researchers at all levels of development, from basic laboratory investigators to clinical practitioners, will find this book to be instructive.

Cancer gene therapy, like cancer therapy in general, is evolving rapidly, testing new concepts, targets and pathways, evoking new technologies, and passing new regulatory hurdles. Its essence, however, has not changed: the hope and challenges of returning altered genes to normal, using targeted gene expression to alter the function of both tumor and microenvironment, and in some cases normal cells, and delivering functionally important genes to specific cell types to increase sensitivity to killing or to protect normal cells from cancer therapies.

In some instances, gene therapy for cancer forms a continuum from gene repair through the use of molecularly modified cells; the use of viral and non-viral vector based gene delivery to both tumor and tumor microenvironment; the use of viral and gene based vaccines; and development of new gene-based therapeutics. The unique mechanistically chosen vector platforms are at the heart of this technology because they allow for direct and selective cell death and transient to sustained delivery of vaccine molecules or molecules that affect the microenvironment, vasculature, or the immune response.

  • Explains the underlying cancer biology necessary for understanding proposed therapeutic approaches
  • Presents in-depth description of targeting systems and treatment strategies
  • Covers the breadth of gene therapy approaches including immunotherapeutic, drug resistance,oncolytic viruses, as well as regulatory perspectives from both the NCI and FDA
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical and clinical studies have led to the design and testing of new therapeutic approaches. The Third Edition of Gene Therapy of Cancer provides crucial updates on the basic and applied sciences of gene therapy. It offers a comprehensive assessment of the field including the areas of suicide gene therapy, oncogene and suppressor gene targeting, immunotherapy, drug resistance gene therapy, and the genetic modification of stem cells. Researchers at all levels of development, from basic laboratory investigators to clinical practitioners, will find this book to be instructive.

Cancer gene therapy, like cancer therapy in general, is evolving rapidly, testing new concepts, targets and pathways, evoking new technologies, and passing new regulatory hurdles. Its essence, however, has not changed: the hope and challenges of returning altered genes to normal, using targeted gene expression to alter the function of both tumor and microenvironment, and in some cases normal cells, and delivering functionally important genes to specific cell types to increase sensitivity to killing or to protect normal cells from cancer therapies.

In some instances, gene therapy for cancer forms a continuum from gene repair through the use of molecularly modified cells; the use of viral and non-viral vector based gene delivery to both tumor and tumor microenvironment; the use of viral and gene based vaccines; and development of new gene-based therapeutics. The unique mechanistically chosen vector platforms are at the heart of this technology because they allow for direct and selective cell death and transient to sustained delivery of vaccine molecules or molecules that affect the microenvironment, vasculature, or the immune response.

More books from Elsevier Science

Cover of the book Introduction to Groundwater Modeling by
Cover of the book Advances in Organometallic Chemistry by
Cover of the book Neutron Scattering from Magnetic Materials by
Cover of the book Trigeminocardiac Reflex by
Cover of the book Toxicity of Building Materials by
Cover of the book Enzymes of Epigenetics by
Cover of the book Introduction to Food Toxicology by
Cover of the book Supra-materials Nanoarchitectonics by
Cover of the book Handbook on the Physics and Chemistry of Rare Earths by
Cover of the book Brewing Microbiology by
Cover of the book The Sedimentary Basins of the United States and Canada by
Cover of the book Fullerens, Graphenes and Nanotubes by
Cover of the book Proceedings of the International Conference on Colloid and Surface Science by
Cover of the book Preservation and Shelf Life Extension by
Cover of the book Heterogeneous Computing with OpenCL by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy